Androgen Deprivation Therapy (ADT) + Apalutamide for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Dec 2018: Trial registered, NCT03767244
  2. 11 Jun 2019: Trial started, NCT03767244

The trials

NCT03767244: A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

State
Under way
Phase
Phase 3
People
2,517 taking part
Started
11 Jun 2019
Primary completion
1 Dec 2026
Arms
Apalutamide + ADT
Results
None posted
  1. 6 Dec 2018: Trial registered
  2. 11 Jun 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.